| Skanska Wins SEK 1 Bln Contract To Build Radioactive Waste Repository Caverns In Sweden | SOLNA (dpa-AFX) - Skanska AB (SKSBF.PK, SKAb.ST) Monday said that it has signed a contract with Svensk Kärnbränslehantering AB to build new rock caverns for the expansion of the Short-Lived... ► Artikel lesen |
| Skanska builds rock caverns for the final repository of short-lived radioactive waste in Forsmark for about SEK 1 billion | STOCKHOLM, July 6, 2026 /PRNewswire/ -- Skanska has signed a contract with Svensk Kärnbränslehantering AB (SKB) for the construction of new rock caverns for the short-lived radioactive waste... ► Artikel lesen |
| Skanska AB: Skanska builds rock caverns for the final repository of short-lived radioactive waste in Forsmark for about SEK 1 billion | Skanska has signed a contract with Svensk Kärnbränslehantering AB (SKB) for the construction of new rock caverns for the short-lived radioactive waste (SFR) final repository in Forsmark, Sweden. The... ► Artikel lesen |
| EQT AB To Acquire Orikan | WASHINGTON (dpa-AFX) - EQT AB, through its BPEA EQT Mid-Market Growth Partnership, has agreed to acquire Melbourne-based parking technology provider Orikan Group Pty Ltd. for undisclosed terms.... ► Artikel lesen |
| Invitation to presentation of EQT AB's Half-year Report 2026 | STOCKHOLM, July 3, 2026 /PRNewswire/ -- EQT AB's Half-year Report 2026 will be published on Friday 17 July 2026 at approximately 07:00 CEST. EQT will host a conference call at 08:30 CEST... ► Artikel lesen |
| The AES Corporation: AES Stockholders Approve Acquisition by Global Infrastructure Partners and EQT-Led Consortium | ARLINGTON, Va., June 26, 2026 /PRNewswire/ -- The AES Corporation (the "Company" or "AES") (NYSE: AES) today announced that its stockholders voted to approve the... ► Artikel lesen |
| Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO for NSCLC | SHANGHAI, July 1, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered... ► Artikel lesen |
| AstraZeneca PLC: Admission of Further Securities to Trading | 1 July 2026
Notification of Admission of Further Securities to Trading (PRM 1.6.4R)
The following notification is made in accordance with The Public Offers and Admissions to Trading Regulations 2024... ► Artikel lesen |
| GOLDMAN SACHS stuft ASTRAZENECA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Astrazeneca von 16525 auf 16370 Pence gesenkt, aber die Einstufung auf "Buy" belassen. Für das zweite Quartal sieht... ► Artikel lesen |